Green Coffee Extract Improves Cardiometabolic Parameters and Modulates Gut Microbiota in High-Fat-Diet-Fed ApoE-/- Mice

Autor: Julio C. Jaramillo, Katalina Muñoz-Durango, Eliana P. Velásquez-Mejía, Sonia Medina, Juan S. Escobar, Yudy M. León-Varela, Jelver Sierra, José R. Ramírez-Pineda, Mauricio Naranjo, Jorge H. Tabares-Guevara, Rafael Álvarez-Quintero, Erika Caro-Gómez
Jazyk: angličtina
Rok vydání: 2019
Předmět:
Liver Cirrhosis
0301 basic medicine
medicine.medical_specialty
medicine.medical_treatment
Adipose tissue
lcsh:TX341-641
Coffea
Gut flora
Diet
High-Fat

Article
Mice
03 medical and health sciences
Apolipoproteins E
0302 clinical medicine
Insulin resistance
Blood serum
gut dysbiosis
Non-alcoholic Fatty Liver Disease
Internal medicine
NAFLD
medicine
Animals
Mice
Knockout

Nutrition and Dietetics
biology
Plant Extracts
Chemistry
Insulin
Leptin
Fatty liver
high fat diet
biology.organism_classification
medicine.disease
Gastrointestinal Microbiome
immune system
030104 developmental biology
Endocrinology
Adipose Tissue
Gene Expression Regulation
Liver
green coffee
030220 oncology & carcinogenesis
Green coffee extract
cardiometabolic syndrome
Insulin Resistance
atherosclerosis
Energy Metabolism
lcsh:Nutrition. Foods and food supply
Food Science
Zdroj: Nutrients
Volume 11
Issue 3
Nutrients, Vol 11, Iss 3, p 497 (2019)
ISSN: 2072-6643
DOI: 10.3390/nu11030497
Popis: Chlorogenic acids (CGA) are the most abundant phenolic compounds in green coffee beans and in the human diet and have been suggested to mitigate several cardiometabolic risk factors. Here, we aimed to evaluate the effect of a water-based standardized green coffee extract (GCE) on cardiometabolic parameters in ApoE-/- mice and to explore the potential underlying mechanisms. Mice were fed an atherogenic diet without (vehicle) or with GCE by gavage (equivalent to 220 mg/kg of CGA) for 14 weeks. We assessed several metabolic, pathological, and inflammatory parameters and inferred gut microbiota composition, diversity, and functional potential. Although GCE did not reduce atherosclerotic lesion progression or plasma lipid levels, it induced important favorable changes. Specifically, improved metabolic parameters, including fasting glucose, insulin resistance, serum leptin, urinary catecholamines, and liver triglycerides, were observed. These changes were accompanied by reduced weight gain, decreased adiposity, lower inflammatory infiltrate in adipose tissue, and protection against liver damage. Interestingly, GCE also modulated hepatic IL-6 and total serum IgM and induced shifts in gut microbiota. Altogether, our results reveal the cooccurrence of these beneficial cardiometabolic effects in response to GCE in the same experimental model and suggest potential mediators and pathways involved.
Databáze: OpenAIRE